Metabolic associated fatty liver disease and cardiovascular risk: The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society

被引:4
|
作者
Gorczyca-Glowacka, Iwona [1 ,11 ]
Welnicki, Marcin [2 ]
Mamcarz, Artur [2 ]
Filipiak, Krzysztof J. [3 ]
Wozakowska-Kalpon, Beata [4 ]
Barylski, Marcin [5 ]
Szymanski, Filip M. [6 ]
Kasprzak, Jaroslaw D. [7 ]
Tomasiewcz, Krzysztof [8 ]
Lelonek, Malgorzata [9 ]
Grzesk, Grzegorz [10 ]
机构
[1] Jan Kochanowski Univ Kielce, Coll Medicum, Kielce, Poland
[2] Warsaw Med Univ, Dept Internal Dis & Cardiol 3, Warsaw, Poland
[3] Mar Sklodowska Curie Med Acad Warsaw, Inst Clin Sci, Warsaw, Poland
[4] Swietokrzyskie Cardiol Centerin Kielce, Dept Cardiol & Electrotherapy 1, Kielce, Poland
[5] Med Univ Lodz, Dept Internal Dis & Cardiol Physiotherapy, Lodz, Poland
[6] Cardinal Stefan Wyszynski Univ Warsaw, Dept Civilizat Dis, Coll Medicum, Warsaw, Poland
[7] Med Univ Lodz, Dept Cardiol 1, Lodz, Poland
[8] Med Univ Lublin, Dept Infect Dis, Lublin, Poland
[9] Med Univ Lodz, Dept Noninvas Cardiol, Lodz, Poland
[10] Nicolaus Copernicus Univ Torun, Fac Hlth Sci, Dept Cardiol & Clin Pharmacol, Ludw Rydygier Coll Medicum Bydgoszcz, Torun, Poland
[11] Jan Kochanowski Univ Kielce, Coll Medicum, 9 Wiekow Kielc 19A, PL-25317 Kielce, Poland
关键词
atherosclerotic cardiovascular disease; cardiovascular risk; metabolic associated fatty liver disease; obesity; statin; NONALCOHOLIC STEATOHEPATITIS; ATORVASTATIN; PROGRESSION; STATINS; NAFLD; ATHEROSCLEROSIS; STEATOSIS; MORTALITY; HISTOLOGY; OUTCOMES;
D O I
10.33963/KP.a2023.0022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The diagnosis of metabolic associated fatty liver disease (MAFLD) is significant for patients' progno-sis, as the disease accelerates the development of cardiovascular complications and, on the other hand, cardiometabolic conditions are risk factors for the development of fatty liver diseases. This expert opinion presents principles of MAFLD diagnosis and standards of management to reduce cardiovascular risks in patients with MAFLD.
引用
收藏
页码:207 / 214
页数:8
相关论文
共 50 条
  • [1] Pharmacotherapy of heart failure AD 2023. Expert opinion of Working Group on Cardiovascular Pharmacotherapy, Polish Cardiac Society
    Kasprzak, Jaroslaw D.
    Gorczyca-Glowacka, Iwona
    Sobczak-Kaleta, Maria
    Barylski, Marcin
    Drozdz, Jaroslaw
    Filipiak, Krzysztof J.
    Kaplon-Cieslicka, Agnieszka
    Lelonek, Malgorzata
    Mamcarz, Artur
    Ochijewicz, Dorota
    Rys-Czaporowska, Anna
    Starzyk, Katarzyna
    Szymanski, Filip M.
    Welnicki, Marcin
    Wozakowska-Kaplon, Beata
    [J]. KARDIOLOGIA POLSKA, 2023, 81 (05) : 537 - 556
  • [2] An expert opinion of the Association of Cardiovascular Interventions and the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society related to the place of prasugrel in the prevention of cardiovascular events in patients with acute coronary syndromes
    Barylski, Marcin
    Legutko, Jacek
    Lesiak, Maciej
    Bartus, Stanislaw
    Mamcarz, Artur
    Wozakowska-Kaplon, Beata
    Grygier, Marek
    Wojakowski, Wojciech
    Witkowski, Adam
    Stepinska, Janina
    Kuliczkowski, Wiktor
    [J]. KARDIOLOGIA POLSKA, 2022, 80 (01) : 113 - 122
  • [3] The use of GLP-1 analogs in treatment of diabetes in patients with cardiovascular diseases. The expert opinion of the Working Group of Cardiovascular Pharmacotherapy of the Polish Cardiac
    Welnicki, Marcin
    Gorczyca-Glowacka, Iwona
    Mamcarz, Artur
    Filipiak, Krzysztof J.
    Wozakowska-Kaplon, Beata
    Barylski, Marcin
    Szymanski, Filip M.
    Kasprzak, Jaroslaw
    Grabowski, Marcin
    Dzida, Grzegorz
    Zozulinska-Ziolkiewicz, Dorota
    Jankowski, Piotr
    [J]. KARDIOLOGIA POLSKA, 2022, 80 (12) : 1286 - 1298
  • [4] Combination therapy in the management of hypertension - current problem in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy
    Wozakowska-Kaplon, Beata
    Filipiak, Krzysztof J.
    Czarnecka, Danuta
    Dzida, Grzegorz
    Mamcarz, Artur
    Tykarski, Andrzej
    Widecka, Krystyna
    Narkiewicz, Krzysztof
    [J]. KARDIOLOGIA POLSKA, 2013, 71 (04) : 433 - 438
  • [5] Combination therapy in the management of hypertension - current problem in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy
    Wozakowska-Kaplon, Beata
    Filipiak, Krzysztof J.
    Czarnecka, Danuta
    Dzida, Grzegorz
    Mamcarz, Artur
    Tykarski, Andrzej
    Widecka, Krystyna
    Narkiewicz, Krzysztof
    [J]. ARTERIAL HYPERTENSION, 2013, 17 (01): : 3 - 9
  • [6] Metabolic-associated fatty liver disease and the risk of cardiovascular disease
    Zhang, Pengwei
    Dong, Xianhui
    Zhang, Wei
    Wang, Shiyin
    Chen, Chen
    Tang, Jiake
    You, Yao
    Hu, Siqi
    Zhang, Shenghui
    Wang, Chunyi
    Wen, Wen
    Zhou, Mengyun
    Tan, Tao
    Qi, Guanming
    Li, Li
    Wang, Mingwei
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (01)
  • [7] The role of pneumococcal vaccination in reducing cardiovascular risk in cardiac patients: Expert opinion of the Prevention Committee of the Polish Cardiac Society supported by the Polish Vaccinology Society
    Mamcarz, Artur
    Welnicki, Marcin
    Drozdz, Jaroslaw
    Grabowski, Marcin
    Jankowski, Piotr
    Kuchar, Ernest
    Leszek, Przemyslaw
    Mitkowski, Przemyslaw
    Wysocki, Jacek
    Kopec, Grzegorz
    Antczak, Adam
    [J]. KARDIOLOGIA POLSKA, 2023, 81 (10) : 1038 - 1046
  • [8] Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy
    Tykarski, Andrzej
    Widecka, Krystyna
    Narkiewicz, Krzysztof
    Wozakowska-Kaplon, Beata
    Gaciong, Zbigniew
    Grajek, Stefan
    Grodzicki, Tomasz
    Januszewicz, Andrzej
    Wolf, Jacek
    Prejbisz, Aleksander
    Kostka-Jeziorny, Katarzyna
    Filipiak, Krzysztof J.
    [J]. KARDIOLOGIA POLSKA, 2017, 75 (12) : 1357 - 1367
  • [9] Management of dyslipidemia in Poland: Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. The Fourth Declaration of Sopot
    Szymanski, Filip M.
    Mickiewicz, Agnieszka
    Dzida, Grzegorz
    Gorczyca-Glowacka, Iwona
    Kozlowski, Dariusz
    Widecka, Krystyna
    Krasinski, Zbigniew
    Kobayashi, Adam
    Hering, Dagmara
    Mizia-Stec, Katarzyna
    Kasprzak, Jaroslaw D.
    Zubilewicz, Tomasz
    Narkiewicz, Krzysztof
    Kozinski, Marek
    Platek, Anna E.
    Rys-Czaporowska, Anna
    Chelstowska, Beata
    Grajek, Stefan
    Welnicki, Marcin
    Mamcarz, Artur
    Barylski, Marcin
    Wozakowska-Kaplon, Beata
    Jaguszewski, Milosz J.
    Gruchala, Marcin
    Filipiak, Krzysztof J.
    [J]. CARDIOLOGY JOURNAL, 2022, 29 (01) : 1 - 26
  • [10] The European Society of Cardiology working group on cardiovascular pharmacotherapy
    Kaski, Juan Carlos
    Niessner, Alexander
    Dobrev, Dobromir
    Rocca, Bianca
    [J]. EUROPEAN HEART JOURNAL, 2023, 44 (42) : 4400 - 4402